Skip to Main Content
Skip Nav Destination

Neurodegenerative Diseases


The International Journal of Translational Research on the Nervous System

Editor: Allali, G. (Lausanne)

Editorial Board

Submit manuscript

Platform of the Neurodegenerative Research Community, Fast Peer Review

Neurodegenerative Diseases is a multidisciplinary journal dedicated to publishing and discussing advances in research on all aspects of neurodegenerative diseases. The journal focuses on Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and Huntington disease but also welcomes articles on related neurological and psychiatric disorders. It has a particular emphasis on the interplay between vascular pathology, neuroinflammatory change, and the progression of neurodegenerative disease. In addition to clinical and basic science studies, brief methodological papers are welcome in the emerging fields of statistical genetics, clinical and preclinical neuroimaging, novel algorithms of biomedical image computing, and other approaches elucidating mechanisms of neurodegenerative disease. Neurodegenerative Diseases accepts high-quality papers in the form of brief reports, research articles, and review articles from a broad spectrum of scientific research areas ranging from neuroscience and genetics to clinical and preclinical neuroimaging and biomarker studies, molecular and cell biology, as well as pharmacology. All articles undergo rigorous scientific as well as statistical/bioinformatic peer review to ensure excellence. The journal provides fast peer review and provides opportunities for open-access publication.

About this Journal

Calls for Papers

Anti-amyloid Drugs: A Therapeutical Revolution in Alzheimer’s Disease
Extended Submission Deadline: December 31, 2024

Sex and Gender in Neurodegenerative Diseases
Submission Deadline: September 30, 2024

Journal Details

For Authors

Publish your paper with us.

Author Guidelines

Cost of Publication

Editors and Reviewers

Login to our peer review system.

Affiliations

Logo of the Kuwait University Health Sciences Centre

Neurodegenerative Diseases is the official journal of Société Francophone Posture Équilibre et Locomotion (SOFPEL). Membership to the society includes free online access to the journal, exemption of Page Charges and 25% discount on Author’s Choice fee. If you are a SOFPEL member and have questions, contact us and we will be happy to help.

News & Highlights

Outstanding Reviewers 2023

The Outstanding Reviewer Award for the year 2023 is presented to Prof. Elizabeta Blagoja Mukaetova-Ladinska from the University of Leicester, Leicester, UK and Prof. Tyle Reekes from the Duke University Medical Center, Durham, NC, USA. We are grateful for their ongoing support and invaluable contributions.

Karger Publishers recognizes the valuable work of reviewers in various ways.

LEARN MORE

Neurodegenerative Diseases is Member of NPRC

The Neuroscience Peer Review Consortium (NPRC) is an alliance of neuroscience journals that share manuscript reviews with other NPRC members at the author's request. The NPRC system facilitates fast-track review and publication of neuroscience research, and reduces the burden on peer reviewers.

Read More

New Editor-in-Chief:
Gilles Allali

Portrait Gilles Allali

On the 1st of August 2023, a new cycle initiated for Neurodegenerative Diseases. We welcome Prof. Gilles Allali, head of the Leenaards Memory Centre – CHUV Lausanne, Switzerland, as the new Editor-in-Chief of Neurodegenerative Diseases. Our heartfelt thanks to Prof. Unschuld who led the Journal as Editor-in-Chief for the past 5 and a half years.

Read the Publisher's Note marking this change in leadership: New editorship of Neurodegenerative Diseases

And Prof. Allali’s editorial: A Pivotal Time

Congress Announcements

Have a look at all events related to this journal.

View more

Issues & Articles

Connect with Us

Follow us on X
@NeuroKarger

Check out our X feed.

Follow us

Stay Up-to-Date

Get news according to your interests.

SUBSCRIBE NOW

Recommend this Journal

Suggest this journal via social media or e-mail to your colleagues.

Close Modal

or Create an Account

Close Modal
Close Modal